Equillium Inc. [NASDAQ: EQ] gained 0.60% or 0.06 points to close at $10.11 with a heavy trading volume of 1971250 shares. The company report on August 10, 2020 that Equillium Announces Positive Interim Data with Itolizumab in Acute GVHD Study.
Complete response observed in five of seven patients in first two dose cohorts.
COVID-19 Pre-IND meeting request and briefing package submitted to the FDA.
It opened the trading session at $12.00, the shares rose to $12.29 and dropped to $10.02, the range by which the price of stock traded the whole day. The daily chart for EQ points out that the company has recorded 104.24% gains over the past six months. However, it is still -359.55% lower than its most recent low trading price.
If we look at the average trading volume of 2.50M shares, EQ reached to a volume of 1971250 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Equillium Inc. [EQ]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for EQ shares is $16.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on EQ stock is a recommendation set at 1.20. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for Equillium Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on July 14, 2020. While these analysts kept the previous recommendation, Stifel dropped their target price from $22 to $10. The new note on the price target was released on July 10, 2020, representing the official price target for Equillium Inc. stock. Previously, the target price had yet another raise to $16, while SVB Leerink analysts kept a Outperform rating on EQ stock.
The Average True Range (ATR) for Equillium Inc. is set at 2.19 The Price to Book ratio for the last quarter was 4.88, with the Price to Cash per share for the same quarter was set at 2.62.
Trading performance analysis for EQ stock
Equillium Inc. [EQ] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -2.51. With this latest performance, EQ shares dropped by -61.85% in over the last four-week period, additionally plugging by 104.24% over the last 6 months – not to mention a rise of 183.99% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for EQ stock in for the last two-week period is set at 50.99, with the RSI for the last a single of trading hit 47.42, and the three-weeks RSI is set at 52.77 for Equillium Inc. [EQ]. The present Moving Average for the last 50 days of trading for this stock 7.20, while it was recorded at 10.00 for the last single week of trading, and 4.60 for the last 200 days.
Equillium Inc. [EQ]: A deeper dive into fundamental analysis
Return on Total Capital for EQ is now -45.90, given the latest momentum, and Return on Invested Capital for the company is -43.96. Return on Equity for this stock declined to -47.95, with Return on Assets sitting at -41.73. When it comes to the capital structure of this company, Equillium Inc. [EQ] has a Total Debt to Total Equity ratio set at 23.13. Additionally, EQ Total Debt to Total Capital is recorded at 18.79, with Total Debt to Total Assets ending up at 17.43. Long-Term Debt to Equity for the company is recorded at 23.13, with the Long-Term Debt to Total Capital now at 18.79.
Reflecting on the efficiency of the workforce at the company, Equillium Inc. [EQ] managed to generate an average of -$1,600,000 per employee.Equillium Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 13.40 and a Current Ratio set at 13.40.
Equillium Inc. [EQ]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, Equillium Inc. posted -0.35/share EPS, while the average EPS was predicted by analysts to be reported at -0.34/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -2.90%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for EQ.
An analysis of insider ownership at Equillium Inc. [EQ]
There are presently around $37 million, or 25.70% of EQ stock, in the hands of institutional investors. The top three institutional holders of EQ stocks are: VICTORY CAPITAL MANAGEMENT INC with ownership of 1,728,521, which is approximately -21.361% of the company’s market cap and around 6.40% of the total institutional ownership; FMR LLC, holding 619,843 shares of the stock with an approximate value of $6.27 million in EQ stocks shares; and GOLDMAN SACHS GROUP INC, currently with $5.39 million in EQ stock with ownership of nearly -9.453% of the company’s market capitalization.
Positions in Equillium Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 7 institutional holders increased their position in Equillium Inc. [NASDAQ:EQ] by around 39,050 shares. Additionally, 11 investors decreased positions by around 552,108 shares, while 6 investors held positions by with 3,033,825 shares. The mentioned changes placed institutional holdings at 3,624,983 shares, according to the latest SEC report filing. EQ stock had 4 new institutional investments in for a total of 2,892 shares, while 4 institutional investors sold positions of 16,340 shares during the same period.